GlassScriptPhysician profile
Abid T Javed
NPI 1154859544
$7,151.23
in general payments reported to CMS, 2019-2025
12 companies · $3,184 in 2025
The $3,184 reported for 2025 was more than what 87% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $162 · 2023: $457 · 2024: $3,349 · 2025: $3,184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,572 · Food and Beverage: $3,417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,571.73 |
| Food and Beverage | $3,417.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,287.02 | 2022-2025 | Axios, Overstitch Endoscopic Suturing System, Exalt Model D |
| Ovesco Endoscopy USA, INC. | $587.46 | 2025 | |
| Erbe USA INC | $200.00 | 2025 | Vio3/Apc3, Vio3 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $190.80 | 2025 | Xifaxan |
| Janssen Scientific Affairs, LLC | $182.07 | 2022-2024 | |
| Conmed Corporation | $154.74 | 2024 | Conmed Biliary |
| Exact Sciences Corporation | $142.79 | 2023 | Cologuard Collection Kit |
| Medtronic, INC. | $110.21 | 2023 | Endoflip |
| Madrigal Pharmaceuticals | $102.07 | 2025 | Rezdiffra |
| Amgen INC. | $87.86 | 2025 | Uplizna |
| Fujifilm Healthcare Americas Corporation | $75.00 | 2023 | |
| Creo Medical INC. | $31.21 | 2024 | Speedboat Ultraslim (Sb1l) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abid Javed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.